Back to search
Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients (pts) with locally advanced rectal cancer (LARC): Results of the ACCORD 12/0405 PRODIGE 2
Data up to Jan 2025
Published2009
Citations16
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database